Promoter holding
64.27%
UP
Umang Pharmatech Pvt Ltd - Due diligence report
A 360° intelligence report on Umang Pharmatech Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and distre…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Umang Pharmatech Pvt Ltd — 360° Intelligence Report
Generated from MCA filings & public records73/100
Trust Score
Moderate
Umang Pharmatech Pvt Ltd is assessed as Moderate with a Trust Score of 73/100. Umang Pharmatech Pvt Ltd is an active private limited indian non-government company incorporated in 1992, operating in the FMCG sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Umang Pharmatech Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
73/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
86/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- Working-capital cover adequate.
Charges position: 1 open (5.00 Lakh) · 10 satisfied (53.30 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 2 | 48.0 cr |
| Bassein Catholic Co-Op. Bank Ltd | 2 | 48.0 cr |
| Bassein Catholic Co-Operative Bank Limited | 2 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
| The Bassein Catholic Co-Op Bank Limited | 1 | 48.0 cr |
| Bassein Catholic Co-Op. Bank Ltd. | 1 | 48.0 cr |
Compliance Score: 86/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PAYAL BUDHRAJA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RENU BUDHRAJA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| UMANG RAJKUMAR BUDHRAJA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 1 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Caleva Process Solutions Limited | Subsidiary Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 60
Growth signals & trust indicators
Operating for 34+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
1 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment54/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 5.00 Lakh already registered.
- Compliance record supports lending.
Investor view48/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
05 Feb 2024
Charge satisfied
Axis Bank Limited
29 Sep 2023
Director ceased
PAYAL BUDHRAJA
31 Mar 2023
Share transfer (FY 2023)
138333.00000000 shares to Renu Rajkumar Budhraja
11 Mar 2023
Director appointed
PAYAL BUDHRAJA (Director)
12 Feb 2023
Director ceased
RAJ KUMAR BUDHRAJA
02 Jun 2022
Charge satisfied
Others
28 Apr 2021
Charge created
Axis Bank Limited - 4.40 cr
20 Jan 2020
Director appointed
UMANG RAJKUMAR BUDHRAJA (Director)
05 Apr 2019
Charge satisfied
Others
Charge satisfied
Bassein Catholic Co-Operative Bank Limited
28 Jun 2018
Charge created
Others - 11.26 cr
03 Oct 2016
Charge created
Others - 13.00 cr
28 Jul 2015
Charge satisfied
The Bassein Catholic Co-Op Bank Limited
10
Key Observations
Auto-generated from the data aboveRevenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Heni Drugs Pvt Ltd | U24139MH1993PTC070791 | Mumbai, Maharashtra, India |
| Rainbow Petrochem Industries Private Limited | U74899DL1994PTC061060 | New Delhi, Delhi, India |
| Avani Silicates Private Limited | U24110RJ2020PTC068274 | Jaipur, Rajasthan, India |
| Briyosis | U24231GJ2004PTC044846 | Circle Vadodara, Gujarat, India |
| Meghalaya Bitchem Private Limited | U23209ML2004PTC007399 | Ri Ribhoi District, Meghalaya, India |
| Value Chem Private Limited | U24100TG2016PTC103511 | Serilingampally, Telangana, India |
| Anshul Innovative Chemistry Private Limited | U24290MH2020PTC336416 | Mumbai, Maharashtra, India |
| Sheetal Chemicals Private Limited | U24239TG2004PTC043635 | Hyderabad, Telangana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Umang Pharmatech Pvt Ltd before audits and certifications: compliance score 86/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Umang Pharmatech Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Umang Pharmatech Pvt Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 73/100, distress signals and MSME payment-delay disclosures - know whether Umang Pharmatech Pvt Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Umang Pharmatech Pvt Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Umang Pharmatech Pvt Ltd an active company?
Umang Pharmatech Pvt Ltd has MCA status “Active” with a compliance score of 86/100 (Low Risk).
Is Umang Pharmatech Pvt Ltd financially healthy?
Umang Pharmatech Pvt Ltd has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Umang Pharmatech Pvt Ltd?
Its overall Trust Score is 73/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Umang Pharmatech Pvt Ltd?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Umang Pharmatech Pvt Ltd have loans or charges against its assets?
1 open charge(s) are registered against its assets, and 10 earlier charge(s) stand satisfied.
Is Umang Pharmatech Pvt Ltd up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 86/100 (Low Risk).
Is it risky to lend to Umang Pharmatech Pvt Ltd?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
